| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 10/18/2006 | CN1279904C Vitamin C composition containing sodium vitamin C |
| 10/18/2006 | CN1279902C Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents |
| 10/17/2006 | US7122679 Multicyclic compounds and the use thereof |
| 10/17/2006 | US7122673 Cyclization of imines to form compounds such as 4-Phenyl-6H-(1)Benzopyrano(4',3':4,5)pyrrolo(2,1-a)isoquinolin-6-one, used as nontoxic modulators of multidrug resistant cells; antitumor agents |
| 10/17/2006 | US7122670 Adding a Lewis acid to the reaction medium selectively adds an amine functionality to the C-2 position of a CF3 substituted-pyrimidine ring; treating abnormal cell growth, cancer, in mammals |
| 10/17/2006 | US7122669 Purine derivatives, preparation method and pharmaceutical compositions containing same |
| 10/17/2006 | US7122668 Platinum complexes and their use in therapy |
| 10/17/2006 | US7122652 Isolated polynucleotide encoding a variant human pregnane X receptor (hPXR) polypeptide or fragment; detection and genotyping of hPXR alleles in humans, homozygous as well as heterozygous, alleles of the hPXR gene |
| 10/17/2006 | US7122643 Cytostatic lanthanum compounds |
| 10/17/2006 | US7122639 Chemokine alpha-2 antibodies |
| 10/17/2006 | US7122635 Method and composition for angiogenesis inhibition |
| 10/17/2006 | US7122629 For forensic analyses, chromosome tissue/cell/organelle-specific markers, production of expression vectors, screening and diagnosis assays |
| 10/17/2006 | US7122573 A flavonoids, anticarcinogenic agents for treating cancer, such as catechin, epigallocatichin-3-gallate |
| 10/17/2006 | US7122554 Sexual disorders therapy; hypotensive agents; chronic obstructive pulmonary disease; congestive heart failure; asthma; antiallergens |
| 10/17/2006 | US7122552 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction |
| 10/17/2006 | US7122551 Metalloproteinase inhibitor compounds |
| 10/17/2006 | US7122550 Protein kinase inhibitors |
| 10/17/2006 | US7122549 For therapy of cancer |
| 10/17/2006 | US7122548 Triazolotriazine compounds and uses thereof |
| 10/17/2006 | US7122547 Anthranilic acid amides and the use thereof as medicaments |
| 10/17/2006 | US7122544 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
| 10/17/2006 | US7122543 Substituted benzoic acid derivatives having NF-κB inhibiting action |
| 10/17/2006 | US7122541 LIVER CANCER; ADMINISTERING TAUROLIDINE, direct contact a liver tissue by perfusion in situ, to increase caspase activity in a cell |
| 10/17/2006 | US7122530 24-hydroxyvitamin D, analogs and uses thereof |
| 10/17/2006 | US7122523 Methods for inhibiting tumor cell proliferation |
| 10/17/2006 | US7122517 Crystallized structure of type IV collagen NC1 domain hexamer |
| 10/17/2006 | US7122362 For diagnosing, treating, or preventing disorders associated with aberrant expression of human phosphodiesterases |
| 10/17/2006 | US7122360 Polypeptides, polynucleotides and uses thereof |
| 10/17/2006 | US7122344 Production of recombinant human uteroglobin (rhUG) for use as a therapeutic in the treatment of inflammation and fibrotic diseases. The invention provides processes, including bacterial expression and protein purification and scaled |
| 10/17/2006 | US7122336 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 10/17/2006 | US7122318 measuring integrin expression in platelets of a patient to which the drug (especially a sulfonamide) is administered and determining influence of it on integrin expression in cells other than platelets based on the measured expression amount. |
| 10/17/2006 | US7122187 Treating autoimmune diseases with humanized anti-CD40L antibody |
| 10/17/2006 | US7122182 Treating cancer in humans; obtain human, administer antitumor agent, evaluate tumor response to antitumor agents |
| 10/17/2006 | CA2447405C Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 10/17/2006 | CA2212888C A method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds |
| 10/17/2006 | CA2195557C Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 10/17/2006 | CA2177179C Antagonists to chaperonin 10 |
| 10/17/2006 | CA2125662C Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis |
| 10/17/2006 | CA2087902C Liposome compositions of porphyrin photosensitizers |
| 10/12/2006 | WO2006108155A2 Process for the preparation of anastrozole |
| 10/12/2006 | WO2006108040A1 Substituted indoles and their use as integrin antagonists |
| 10/12/2006 | WO2006107851A1 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases |
| 10/12/2006 | WO2006107756A1 Pyrrolo [2,3-d] imidazoles for the treatment of hyperproliferative disorders |
| 10/12/2006 | WO2006107059A1 Medicine for renal perfusion disorder |
| 10/12/2006 | WO2006106984A1 Potentiator for radiation therapy comprising pyridine derivative as active ingredient |
| 10/12/2006 | WO2006106983A1 Radiotherapy enhancer |
| 10/12/2006 | WO2006106959A1 Anti-cd-20 monoclonal antibody |
| 10/12/2006 | WO2006106926A1 Lignane compound-containing oil-in-water emulsion and composition comprising the same |
| 10/12/2006 | WO2006106914A1 Novel cyclic compound having pyrimidinylalkylthio group |
| 10/12/2006 | WO2006106912A1 Cancer-associated antigen analog peptide and utilization of the same |
| 10/12/2006 | WO2006106812A1 Propane-1,3-dion derivative or salt thereof |
| 10/12/2006 | WO2006106778A1 Bcrp/abcg2 inhibitor |
| 10/12/2006 | WO2006106721A1 Pyrimidine derivative having tyrosine kinase inhibitory effect |
| 10/12/2006 | WO2006106705A1 Oil/fat-containing composition for suppression of cancer development |
| 10/12/2006 | WO2006106599A1 Pharmaceutical for preventing and/or treating disease caused by abnormal enhancement of extracellular domain shedding |
| 10/12/2006 | WO2006106307A1 Pyrimidine derivatives for use as anticancer agents |
| 10/12/2006 | WO2006106306A1 Pyrimidines as igf-i inhibitors |
| 10/12/2006 | WO2006106046A1 Substituted 1,5-naphthyridine azolidinones as cdk inhibitors |
| 10/12/2006 | WO2006105979A1 Sulfonylpyrroles as histone deacetylase inhibitors |
| 10/12/2006 | WO2006105865A1 Indazole squaric acid derivatives as chk1-, chk2- and sgk- inhibitors |
| 10/12/2006 | WO2006105844A1 Pyrazole derivatives |
| 10/12/2006 | WO2006105811A1 Compounds useful as modulators of the proteasome activity |
| 10/12/2006 | WO2006105806A1 Delaying the ageing process and disorders caused by ageing |
| 10/12/2006 | WO2006105725A1 A combination of luteolin and one of pt chemotherapeutics |
| 10/12/2006 | WO2006105697A1 Piperidyl-2, 6-dione derivatives used to inhibit cells from releasing tumor necrosis factor |
| 10/12/2006 | WO2006090129A3 Bicalutamide for delivering increasing steady state plasma levels |
| 10/12/2006 | WO2006087637A3 Anti her2/neu antibody |
| 10/12/2006 | WO2006078283A3 Quinoxaline inhibitors of hedgehog signalling |
| 10/12/2006 | WO2006073443A3 Antagonist anti-cd40 monoclonal antibodies and methods for their use |
| 10/12/2006 | WO2006072589A3 Disubstituted ureas as kinase inhibitors |
| 10/12/2006 | WO2006066956A3 Sulfonamido-macrocycles as tie2 inhibitors |
| 10/12/2006 | WO2006066914A3 Carbamate substituted imidazo- and pyrrolo-pyridines as protein kinase inhibitors |
| 10/12/2006 | WO2005118592A8 Tetrahydropyridothiophenes for use in the treatment of cancer |
| 10/12/2006 | WO2005105753A8 Naphthalimide derivatives, methods for their production and pharmaceutical compositions therefrom |
| 10/12/2006 | WO2003073821A3 Shc PROTEIN-RELATED METHODS AND COMPOSITIONS FOR THE PROGNOSIS OF BREAST, PROSTATE AND OVARIAN CANCER |
| 10/12/2006 | US20060230467 Plant deoxyribonucleoside kinase enzymes and their use |
| 10/12/2006 | US20060229706 Drug-Delivery Endovascular Stent and Method for Treating Restenosis |
| 10/12/2006 | US20060229456 Diazotizing a blocked 5-amino-1H-imidazole-4-carboxamide; hydrolysis; antitumor agents |
| 10/12/2006 | US20060229446 Structural carotenoid analogs for the inhibition and amelioration of disease |
| 10/12/2006 | US20060229436 activation of alpha-lactalbumin comprising contacting (in molten globule-like state) with fatty acids and lipids found in milk fractions containing casein obtained from humans; antibacterial agents; anticancer agents |
| 10/12/2006 | US20060229353 Substituted heterocycles |
| 10/12/2006 | US20060229345 Compositions comprising epothilones and their use for the treatment of carcinoid syndrome |
| 10/12/2006 | US20060229333 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 10/12/2006 | US20060229329 Such as 2-anilino-4-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)pyrimidine; antiproliferative agents; rheumatoid arthritis |
| 10/12/2006 | US20060229313 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 10/12/2006 | US20060229306 4-(4-Ethylpiperazin-1-yl)-5-methyl-2-phenylthieno[2,3-d]pyrimidine-6-carbonitrile; asthma, atopic dermatitis, chronic obstructive pulmonary disease, Crohn's disease, type I and type II diabetes, lymphoid leukemia and other forms of cancer, multiple sclerosis and autoimmune diseases |
| 10/12/2006 | US20060229301 To treat inflammatory diseases, immune diseases like autoimmune diseases or allergic diseases, or HIV infection; chemokine receptor antagonists; safe and low-toxic; 1-butyl-3-isobutyl-1,3,8-triazaspiro[4.5]decane-2,4-dione |
| 10/12/2006 | US20060229296 1-[4-(2-Azepan-1-yl-ethoxy)-benzyl-2-(4-hydroxy-phenyl])-3-methyl-1H-indol-5-ol, or salts for treating bone loss |
| 10/12/2006 | US20060229273 High affinity oligonucleotide ligands to growth factors |
| 10/12/2006 | US20060229264 Crystalline 6-n-pyridylmethylaminoindolocarbazole compounds |
| 10/12/2006 | US20060229255 Identification of n-alkylglycine trimers for induction of apoptosis |
| 10/12/2006 | US20060229245 Lyophilized HGF preparations |
| 10/12/2006 | US20060229239 Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis |
| 10/12/2006 | US20060229236 Cyclic tetrapeptide compound and use thereof |
| 10/12/2006 | US20060228782 Blood coagulation factor; nucleotide encodes polypeptide; amino acid sequence differs from wild-type FVII or FVIIa; amino acid residue attachment group for non-polypeptide moiety has been introduced or removed; host cell is gammacarboxylating capable of in vivo glycosylation; coagulation disorders |
| 10/12/2006 | US20060228752 Genetic polymorphisms in the preprotachykinin gene |
| 10/12/2006 | US20060228745 Gene detection assay for improving the likelhood of an effective response to an ErbB antagonist cancer therapy |
| 10/12/2006 | US20060228426 Plant extracts for treatment of angiogenesis and metastasis |
| 10/12/2006 | US20060228407 Enhanced delivery via serpin enzyme complex receptor |
| 10/12/2006 | US20060228370 7a5/Prognostin and use thereof for the diagnostic and therapy of tumors |